Adherence and Persistence to Injectable versus Oral GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus: A Comparative Systematic Review and Analysis
Diabetes, Metabolic Syndrome and Obesity · 2026-10 · Volume 19 · 1-12
DOI: 10.2147/dmso.s614243 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes, Metabolic Syndrome and Obesity, 2026-10. Verfasst von Ahmed M Ashour. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
ORCID-Profile: Ahmed M Ashour
Zitieren
APA
Ashour, A. M. (2026). Adherence and Persistence to Injectable versus Oral GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus: A Comparative Systematic Review and Analysis. Diabetes, Metabolic Syndrome and Obesity, Volume 19, 1-12. https://doi.org/10.2147/dmso.s614243
Vancouver
Ashour AM. Adherence and Persistence to Injectable versus Oral GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus: A Comparative Systematic Review and Analysis. Diabetes, Metabolic Syndrome and Obesity. 2026;Volume 19:1-12. doi:10.2147/dmso.s614243
BibTeX
@article{Ashour2026,
author = {Ashour, Ahmed M},
title = {Adherence and Persistence to Injectable versus Oral GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus: A Comparative Systematic Review and Analysis},
journal = {Diabetes, Metabolic Syndrome and Obesity},
year = {2026},
volume = {Volume 19},
pages = {1--12},
doi = {10.2147/dmso.s614243}
}
EUVIMED